GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » EV-to-EBITDA

Shinpoong Pharmaceutical Co (XKRX:019170) EV-to-EBITDA : -47.11 (As of May. 27, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shinpoong Pharmaceutical Co's enterprise value is ₩660,579 Mil. Shinpoong Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-14,023 Mil. Therefore, Shinpoong Pharmaceutical Co's EV-to-EBITDA for today is -47.11.

The historical rank and industry rank for Shinpoong Pharmaceutical Co's EV-to-EBITDA or its related term are showing as below:

XKRX:019170' s EV-to-EBITDA Range Over the Past 10 Years
Min: -311.47   Med: 17.66   Max: 599.42
Current: -47.11

During the past 13 years, the highest EV-to-EBITDA of Shinpoong Pharmaceutical Co was 599.42. The lowest was -311.47. And the median was 17.66.

XKRX:019170's EV-to-EBITDA is ranked worse than
100% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.57 vs XKRX:019170: -47.11

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Shinpoong Pharmaceutical Co's stock price is ₩13100.00. Shinpoong Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1033.671. Therefore, Shinpoong Pharmaceutical Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shinpoong Pharmaceutical Co EV-to-EBITDA Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co EV-to-EBITDA Chart

Shinpoong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.16 262.62 397.89 -47.11 -17.10

Shinpoong Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.96 -24.36 -25.34 -17.10 -56.79

Competitive Comparison of Shinpoong Pharmaceutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Shinpoong Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shinpoong Pharmaceutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shinpoong Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shinpoong Pharmaceutical Co's EV-to-EBITDA falls into.



Shinpoong Pharmaceutical Co EV-to-EBITDA Calculation

Shinpoong Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=660579.284/-14022.834
=-47.11

Shinpoong Pharmaceutical Co's current Enterprise Value is ₩660,579 Mil.
Shinpoong Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-14,023 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shinpoong Pharmaceutical Co  (XKRX:019170) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shinpoong Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13100.00/-1033.671
=At Loss

Shinpoong Pharmaceutical Co's share price for today is ₩13100.00.
Shinpoong Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1033.671.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shinpoong Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shinpoong Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shinpoong Pharmaceutical Co (XKRX:019170) Business Description

Traded in Other Exchanges
Address
161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246
Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co (XKRX:019170) Headlines

No Headlines